InMed Pharmaceuticals Inc.
INM · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$1,727 | -$1,788 | -$2,121 | -$2,575 |
| Dep. & Amort. | $157 | $131 | $130 | $129 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $20 | $27 | $40 | $23 |
| Change in WC | -$59 | -$181 | $265 | -$94 |
| Other Non-Cash | $1 | $33 | $26 | $15 |
| Operating Cash Flow | -$1,608 | -$1,779 | -$1,659 | -$2,502 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$21 | -$2 | -$16 | -$3 |
| Inv. Sales/Matur. | $21 | $2 | $16 | $3 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | $0 | $0 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $3,769 | $2,935 | $396 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$137 | $4,405 | -$15 | -$58 |
| Financing Cash Flow | -$137 | $8,175 | $2,920 | $339 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$1,745 | $6,396 | $1,260 | -$2,164 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $11,076 | $4,680 | $3,419 | $5,583 |
| End Cash | $9,331 | $11,076 | $4,680 | $3,419 |
| Free Cash Flow | -$1,608 | -$1,779 | -$1,659 | -$2,502 |